Viracta Therapeutics, Inc. (VIRX)
NASDAQ: VIRX · Real-Time Price · USD
0.200
+0.006 (2.88%)
At close: Nov 4, 2024, 4:00 PM
0.196
-0.005 (-2.25%)
After-hours: Nov 4, 2024, 4:56 PM EST

Viracta Therapeutics Stock Forecast

VIRX's stock price has decreased by -71.55% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 4 analysts with 12-month price forecasts for VIRX stock have an average target of 5.50, with a low estimate of 3.00 and a high estimate of 11. The average target predicts an increase of 2,650.00% from the current stock price of 0.20.

Analyst Consensus: Buy
Target Low Average Median High
Price $3.00 $5.50 $4.00 $11
Change +1400.0% +2650.0% +1900.0% +5400.0%
* Price targets were last updated on Aug 16, 2024.

Analyst Ratings

The average analyst rating for VIRX stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 222111
Buy 333222
Hold 000111
Sell 000000
Strong Sell 000000
Total 555444

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Leerink Partners
Leerink Partners
Hold
Downgrades
$5$3
Hold Downgrades $5$3 +1,400.00% Aug 16, 2024
RBC Capital
RBC Capital
Buy
Maintains
$6$4
Buy Maintains $6$4 +1,900.00% Aug 15, 2024
Oppenheimer
Oppenheimer
Buy
Maintains
$13$11
Buy Maintains $13$11 +5,400.00% May 23, 2024
Oppenheimer
Oppenheimer
Buy
Maintains
$13
Buy Maintains $13 +6,400.00% Apr 17, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$4
Strong Buy Reiterates $4 +1,900.00% Apr 16, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
3.57M
EPS This Year
-0.89
from -1.32
EPS Next Year
-0.63
from -0.89
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
------3.57M19.75M
Revenue Growth
-------453.11%
EPS
-5.75-58.56-3.60-1.30-1.32-0.89-0.63-0.37
EPS Growth
--------
Forward PE
--------
No. Analysts -----444
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a 7.4M 40.7M
Avg n/a 3.6M 19.7M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High - -
1,038.8%
Avg - -
453.1%
Low - - -

EPS Forecast

EPS 20242025202620272028
High -0.72 -0.37 -0.35
Avg -0.89 -0.63 -0.37
Low -1.03 -0.86 -0.38

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.